Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 8-9, 2009, Pages 765-772

  Ionita, Ileana A ^a,b   Fast, Douglas M ^a   Akhlaghi, Fatemeh ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Assay; Concentration; Cortisol; LC MS MS; Pharmacokinetics; Prednisolone

Indexed keywords

CARBON; CHARCOAL; CONCENTRATION (PROCESS); HIGH PRESSURE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; PLASMA (HUMAN); PRECIPITATION (CHEMICAL); QUALITY ASSURANCE; QUALITY CONTROL; QUALITY FUNCTION DEPLOYMENT; TOTAL QUALITY MANAGEMENT;

ANALYTICAL COLUMNS; BACK PRESSURES; CHROMATOGRAPHIC SEPARATIONS; CONCENTRATION; CONCENTRATION LEVELS; CONCENTRATION RANGES; CORTISOL; FRAGMENTATION PATTERNS; HUMAN PLASMAS; ISOCRATIC CONDITIONS; LC-MS/MS; LOWER LIMIT OF QUANTITATIONS; PHENYL COLUMNS; PLASMA SAMPLES; PREDNISOLONE; PROTEIN PRECIPITATIONS; QUANTITATIVE ANALYSIS; RETENTION TIME; RUN-TIME; SMALL PARTICLES;

PLASMAS;

CORTISONE; HYDROCORTISONE; PREDNISOLONE; PREDNISONE;

ARTICLE; DRUG DETERMINATION; DRUG STRUCTURE; EVAPORATION; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRECIPITATION; PRIORITY JOURNAL;

CHROMATOGRAPHY, LIQUID; CORTISONE; HUMANS; HYDROCORTISONE; PREDNISOLONE; PREDNISONE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 61349092346     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.02.019     Document Type: Article

References (25)

1. Goodwin W.E., Mims M.M., and Kaufman J.J. Trans. Am. Assoc. Genitourin. Surg. 54 (1962) 116
2. Curtis J. Clin. J. Am. Soc. Nephrol. 1 (2006) 907
3. Budde K., Neumayer H.H., Rostaing L., Cantarovich D., Mourad G., and Rigotti P. Transplantation 78 2 (2004) 168
4. Jusko W.J., and Ludwig E.A. Corticosteroids. In: Evans W.E., Scheutag J.J., and Jusko W.J. (Eds). Applied Pharmacokinetics, Principles of Therapeutic Drug Monitoring. 3rd ed. (1992), Applied Therapeutics, Inc., Vancouver, WA 27.1
5. Sorkness C.A., LaForce C., Storms W., Lincourt W.R., Edwards L., and Rogenes P.R. Clin. Ther. 21 (1999) 353
6. Colburn W.A., and Buller R.H. Steroids 21 (1973) 833
7. Sandberg D.H., Bacallao C.Z., and Cleveland W.W. Biochem. Med. 4 (1970) 383
8. Noé S., Böhler J., Keller E., and Frahm A.W. J. Pharm. Biomed. Anal. 18 (1998) 471
9. Loo J.C.K., Butterfield A.G., Moffatt J., and Jordan N. J. Chromatogr. 143 (1977) 275
10. Frey F.J., Frey B.M., and Benet L.Z. Clin. Chem. 25 (1979) 1944
11. Majid O., Akhlaghi F., Lee T., Holt D.W., and Trull A. Ther. Drug Monit. 23 (2001) 163
12. Jusko W.J., Pyszczynski N.A., Bushway M.S., D'Ambrosio R., and Mis S.M. J. Chromatogr. B 658 (1994) 47
13. Shibata N., Hayakawa T., Takada K., Hoshino N., Minouchi T., and Yamaji A. J. Chromatogr. B 706 (1998) 191
14. Zhang Y., Wu H.L., Ding Y.J., Xia A.L., Cui H., and Yu R.Q. J. Chromatogr. B 840 (2006) 116
15. Shibasaki H., Furuta T., and Kasuya Y. J. Chromatogr. 579 (1992) 193
16. Delahaut P., Jacquemin P., Colemonts Y., Dubois M., De Graeve J., and Deluyker H. J. Chromatogr. B: Biomed. Appl. 696 (1997) 203
17. Tai S.S.-C., and Welch M.J. Anal. Chem. 76 (2004) 1008
18. Frerichs V.A., and Tornatore K.M. J. Chromatogr. B 802 (2004) 329
19. van Hout M.W.J., Hofland C.M., Niederlander H.A.G., Bruins A.P., de Zeeuw R.A., and de Jong G.J. J. Chromatogr. B 794 (2003) 185
20. Difrancesco R., Frerichs V., Donnelly J., Hagler C., Hochreiter J., and Tornatore K.M. J. Chromatogr. B 859 (2007) 42
21. Tunn S., Pappert G., Willnow P., and Krieg M. J. Clin. Chem. Clin. Biochem. 12 (1990) 929
22. Nishiyamaa M., Makinoa S., Suemarub S., Nanamiyaa W., Asabaa K., Kanedaa T., Mimotoa T., Nishiokaa T., Takaoa T., and Hashimotoa K. Horm. Res. 54 (2000) 69
23. Shibasaki H., Nakayamaa H., Furutaa T., Kasuyaa Y., Tsuchiyab M., Soejimab A., Yamadab A., and Nagasawab T. J. Chromatogr. B 870 (2008) 164
24. Hariharan M., Naga S., VanNoord T., and Kindt E.K. Clin. Chem. 38 (1992) 346
25. US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Guidance for Industry, Bioanalytical Method Validation, last accessed December 2008, www.fda.gov/cder/guidance/4252fnl.htm.